Overview

This trial is active, not recruiting.

Condition anorexia nervosa
Treatments fbt and crt, fbt and art therapy
Sponsor Stanford University
Collaborator National Institutes of Health (NIH)
Start date November 2013
End date November 2016
Trial size 30 participants
Trial identifier NCT02054364, 1R34MH101281, Grant Funding Number (NIH)

Summary

This study aims to investigate the feasibility of combining Cognitive Remediation Therapy (CRT) with Family Based Treatment (FBT) for future use in a randomized clinical trial to reduce the risk of adolescents developing persistent Anorexia Nervosa. Participants will be randomly assigned to one of two groups: one group will receive FBT and CRT, and the other group will receive FBT and art therapy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
Family-Based Treatment combined with Cognitive Remediation Therapy (15 sessions of each)
fbt and crt Family-Based Treatment (FBT) combined with Cognitive Remediation Therapy (CRT)
(Experimental)
Family-Based Treatment combined with art therapy (15 sessions of each)
fbt and art therapy Family-Based Treatment (FBT) combined with art therapy.

Primary Outcomes

Measure
Full remission from AN (%MBW>95)
time frame: End of Treatment (6 months)

Eligibility Criteria

Male or female participants from 11 years up to 19 years old.

Inclusion Criteria: - Meets DSM-IV criteria for anorexia nervosa Lives with at least one English-speaking parent who is willing to participate Medically Stable Endorses obsessions/compulsions Adequate transportation to clinic Proficient at speaking, reading, and writing English Exclusion Criteria: - Previous FBT or CRT for AN Medical Instability Medical condition that may affect eating or weight

Additional Information

Official title Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia
Principal investigator James Lock, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Stanford University.